The future of cancer treatment is proton therapy

The future of proton therapy
is called ERHA

The advantages of proton therapy

  • Minimal or no side effects

  • Greater radiobiological efficacy

  • Low radiation

  • Targeted dose delivery to the tumor mass

Find out more

The beginning
of a new ERHA

 

First 9 months Radiobiological experimental room Full LINAC up to 65 MeV Radiobiological experimental room Pulsed machine up to 400 Hz (0,2% Duty Cycle)
Intesity modulated current Iavg 1-10 nA
Fixed Energy 65 MeV ± 0,4 MeV
ε(rms,n) = 1,2 π mm mrad
Spotsize: σx=1,4mm, σy=1,6mm
Number of protons for pulse 3x10⁶ - 3x10⁸
Electrical power: 60 kW max, 6 kW standby
Warm up from stanby < 1 hr
Low secondary radiations, activation
LEARN MORE We know that time
is precious
p-Linac Radiobiological
experimental room
The ERHA system can be active from as early as the 9th month from the beginning of the implementation works, and be fully operational within merely 30 months. p-Linac 65 MeV 12 m     30 months 18 months   
protonterapia 18th month Eye and pediatric treatment room Eye and pediatric treatment room Pulsed machine up to 400 Hz (0,2% Duty Cycle)
Intesity modulated current Iavg 1-5 nA
Energy modulated 65-160 MeV ± 0,4 MeV (spread <0,75% over 100MeV )
ε(rms,n) = 1,2 π mm mrad
Spotsize: σx=1,4mm, σy=1,6mm
2 Gy/min FOV 25x25 cm² at 17 cm depth
Number of protons for pulse 3x10⁶ - 3x10⁸
Electrical power: 120 kW max, 8 kW standby
Warm up from stanby < 1 hr
Low secondary radiations, activation
LEARN MORE Eye and pediatric
treatment room
Radiobiological
experimental room
p-Linac The first treatments
from the 18th month
From as early as the 18th month, it will be possible to use a room for pediatric treatments or treatments of the visual system Full LINAC up to 160 MeV p-Linac 160 MeV 18 m 30 months        9 months
30th month Deep tumor treatment room Deep tumor treatment room LEARN MORE Deep tumor
treatment room
Eye and pediatric treatment room Radiobiological experimental room p-Linac ERHA system
ready in 30 months
Implementation of a room for deep tumor treatment Full LINAC up to 230 MeV: protonterapia p-Linac 230 MeV 24 m Pulsed machine up to 400 Hz (0,2% Duty Cycle)
Intesity modulated current Iavg 1-5 nA
Energy modulated 65-230 MeV ± 0,4 MeV (spread <0,75% over 100MeV )
ε(rms,n) = 1,2 π mm mrad
Spotsize: σx=1,4mm, σy=1,6mm
2 Gy/min FOV 25x25 cm² at 32 cm depth
Number of protons for pulse 3x10⁶ - 3x10⁸
Electrical power: 180 kW max, 10 kW standby
Warm up from stanby < 1 hr
Low secondary radiations, activation
    18 months 9 months   

Tumors that can be treated with proton therapy*

* Pathologies treated in Italy in centres already in operation (Source: CNAO)

Brain tumors

Chordomas and chondrosarcomas of the skull base
Tumors of the salivary glands

Mucous melanomas of the upper respiratory tract
Prostate cancer

Chordomas and sacral chondrosarcomas
Ocular melanomas

Tumors of the paranasal sinuses
Lymphomas

Pancreatic cancer

Liver cancer
Rectal cancer

Soft-tissue sarcomas

Proton therapy is considered the most advanced radiotherapy treatment available today.

protonterapia
The most advanced and cutting-edge system to treat tumors
Low side effects to the surrounding tissue
Control of the proton beam

ERHA: proton therapy made in Italy

Proton therapy is an innovative technology that uses beams of protons produced by a particle accelerator to treat tumors. ERHA stands out as a worldwide unique system and this is for the following reasons:

  • Real time control of the LINAC (linear accelerator) with energy and intensity modulation

  • Robotic system for patient positioning

  • Integrated control system with treatment planning software

Spot size Energy modulation Intensity modulation
Cyclotron
Synchrotron
Linac
Comparison between LINAC and other particle accelerators used for ProtonTherapy
FURTHER INFORMATION

5 reasons to choose ERHA, the Enhanced Radiotherapy with Hadrons

linearbeam

Lower price compared to existing systems

linearbeam

Respect for the environment: our system has almost negligible both instant and induced radiations, it avoids the need for large amounts of concrete shielding and it reduces problems of decommissioning and disposal of radioactive waste at the end of its life (20-30 years)

linearbeam

Small footprint: our structure extends mostly in length and requires a surface area of less than 100sqm. Therefore, it has very little impact compared to existing PT structures

linearbeam

Easy to set up in a shielded corridor, a warehouse or a parking lot, as it requires only a small flat surface

linearbeam

Ease of management by operators: the number of devices is reduced and control is achieved by a single software interface

Contact LinearBeam

we will be happy to assist you.

Contact us